TP53 mutations and loss of heterozygosity (LOH) of 17p13 are frequent events in LCNEC (>80%) and SCLC (>90%), but rare in carcinoids [2, 32]. This evidence concerns the gene TP53 and large cell neuroendocrine carcinoma.